Chimiothérapie néoadjuvante par anthracyclines dans le cancer du sein : facteurs prédictifs de réponse

Bensouda, Y.; Ismaili, Nabil; Ahbeddou, N.; Hassani, Kawtar; Chenna, M.; Sbitti, Yassir; Boutayeb, Saber; Errihani, Hassan

doi:10.1016/j.gyobfe.2010.12.004

Search citation statements

Order By: Relevance

Paper Sections

Select...

Chemotherapy and Radiotherapy Treatment1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2014

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 57 publications

(98 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a series of 126 Moroccan patients treated with anthracyclines as neoadjuvant therapy according to AC60 protocol (doxoru bicine+cyclophosphamide), two clinical predictive factors for complete response (CR) and pathological complete response (pCR) were identified: tumor size T2-T3 (T4b were less sensible and T4d did not have a CR), and clinical nodal status N0-N1 (Bensouda et al, 2011). Validating and standardizing these predictors should be valuable and helpful for clinicians.…”

Section: Chemotherapy and Radiotherapy Treatmentmentioning

confidence: 99%

Breast Cancer in Morocco: A Literature Review

Slaoui¹,

Rachid²,

Ibrahimi³

et al. 2014

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

In Morocco, breast cancer is the most prevalent cancer in women and a major public health problem. Several Moroccan studies have focused on studying this disease, but more are needed, especially at the genetic and molecular levels. It is therefore interesting to establish the genetic and molecular profile of Moroccan patients with breast cancer. In this paper, we will highlight some pertinent hypotheses that may enhance breast cancer care in Moroccan patients. This review will give a precise description of breast cancer in Morocco and propose some new markers for detection and prediction of breast cancer prognosis.

show abstract

Section: Chemotherapy and Radiotherapy Treatmentmentioning

confidence: 99%